Galafold (migalastat)

Amenability Table

Full prescribing information

Please provide the information below to be directed to the proper website

1. Choose your Country or Region

2. Confirm Information

Select country or region

Language:

The Galafold Amenability Table website is intended for Health Care Professionals licensed to practice in Argentina.

To enter site, please acknowledge:

The GalafoldAmenabilityTable.com website is intended only for Health Care Professionals licensed to practice in Australia.

To enter site, please acknowledge:

Language:

O website GalafoldAmenabilityTable.com destina-se apenas a Profissionais de Saúde com licença para exercer medicina no Brasil.

Para entrar no website, confirme:

Language:

The GalafoldAmenabilityTable.com website is intended only for Health Care Professionals licensed to practice in Canada.

To enter site, please acknowledge:

Language:

The Galafold Amenability Table website is intended for Health Care Professionals licensed to practice in Chile.

To enter site, please acknowledge:

Language:

Submit

incorrect password

A security code is required to access this website. Please contact your Pint Pharma representative for more information.

The Galafold Amenability Table website is intended for Health Care Professionals licensed to practice in Colombia.

To enter site, please acknowledge:

Language:

The GalafoldAmenabilityTable.com website is intended only for Health Care Professionals licensed to practice in the EU.

To enter site, please acknowledge:

The GalafoldAmenabilityTable.com website is intended only for Health Care Professionals licensed to practice in Great Britain.

Language:

GalafoldAmenabilityTable.comは、医療従事者向けのウェブサイトです。ウェブサイトに移動するには下記を確認してください。

Language:

GalafoldAmenabilityTable.com 웹사이트는 한국의 보건의료 전문가를 위한 사이트입니다.

사이트 접속 전에, 다음을 확인해주십시오.

Language:

GalafoldAmenabilityTable.com 網站僅供取得在中華民國(台灣)執業執照的醫療專業人員使用。

如欲進入網站，請確認：

The GalafoldAmenabilityTable.com website is intended only for Health Care Professionals licensed to practice in the United States.

To enter site, please acknowledge: